Cite
HARVARD Citation
Sunaga, N. et al. (2023). Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report. Anti-cancer drugs. 34 (4), pp. 605-608. [Online].